- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
4.—(1) The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013(1) are amended as follows.
(2) In regulation 6(2) (subsequent assessments)—
(a)before paragraph (1) insert—
“(A1) Any HWB that has not published a pharmaceutical needs assessment before 1st July 2020 must publish its first pharmaceutical needs assessment by 1st April 2022.
(A2) Any HWB that has published a pharmaceutical needs assessment before 1st July 2020 must publish a revised assessment by 1st April 2022 (but it is not required to publish a revised assessment before that date).”;
(b)in paragraph (1), for “pharmaceutical needs assessment,” substitute “or a revised assessment required by 1st April 2022 by virtue of paragraph (A2),”; and
(c)in paragraph (2), before “A HWB must make” insert “After it has published its first or a revised assessment required by 1st April 2022 by virtue of paragraph (A1) or (A2),”,
and in its heading, after “assessments” insert “and later first assessments”.
(3) In Schedule 2 (applications in respect of pharmaceutical lists and the procedures to be followed), in paragraph 34 (taking effect of listing decisions: general)—
(a)in sub-paragraph (4)(b), for “6 months” substitute “12 months”; and
(b)after sub-paragraph (5) insert—
“(6) In any case where a longer period allowed by virtue of sub-paragraph (4)(c)—
(a)began in the 3 months prior to the coming into force of the Coronavirus Regulations, that longer period is extended so that it ends on the day that is 6 months after the day on which the Coronavirus Regulations came into force; and
(b)ended in the 6 months prior to the coming into force of the Coronavirus Regulations, that longer period is treated as having not ended and is extended so that it ends on the day that is 6 months after the day on which the Coronavirus Regulations came into force.
(7) In this paragraph, “the Coronavirus Regulations” means the National Health Service (Coronavirus) (Charges and Further Amendments Relating to the Provision of Primary Care Services During a Pandemic etc.) Regulations 2020.”.
There are no relevant amendments to regulation 6.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: